Royal Bank of Canada’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Royal Bank of Canada’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,430	Closed	–	–	7959
2023 Q2	$0	Buy	+1,430	New	+$563	﹤0.01%	7908
2022 Q4	–	Sell	-820	Closed	–	–	8020
2022 Q3	$0	Buy	820 +653	+391%	+$260	﹤0.01%	8101
2022 Q2	$0	Hold	167	–	–	﹤0.01%	7966
2022 Q1	$0	Hold	167	–	–	﹤0.01%	8171
2021 Q4	$0	Hold	167	–	–	﹤0.01%	8059
2021 Q3	$0	Sell	167 -8,662	-98%	-$15.4K	﹤0.01%	7994
2021 Q2	$14K	Buy	8,829 +3,850	+77%	+$7.14K	﹤0.01%	6757
2021 Q1	$11K	Buy	4,979 +3,979	+398%	+$10.5K	﹤0.01%	6787
2020 Q4	$2K	Sell	1,000 -3,500	-78%	-$7.73K	﹤0.01%	6893
2020 Q3	$11K	Sell	4,500 -2,500	-36%	-$7.28K	﹤0.01%	5903
2020 Q2	$25K	Hold	7,000	–	–	﹤0.01%	5497
2020 Q1	$16K	Hold	7,000	–	–	﹤0.01%	5649
2019 Q4	$15K	Sell	7,000 -5,000	-42%	-$9.87K	﹤0.01%	6000
2019 Q3	$22K	Sell	12,000 -490	-4%	-$857	﹤0.01%	5477
2019 Q2	$18K	Buy	12,490 +7,000	+128%	+$12.2K	﹤0.01%	5773
2019 Q1	$11K	Hold	5,490	–	–	﹤0.01%	5955
2018 Q4	$7K	Sell	5,490 -260	-5%	-$476	﹤0.01%	6064
2018 Q3	$14K	Sell	5,750 -2,091	-27%	-$6.18K	﹤0.01%	5865
2018 Q2	$26K	Buy	7,841 +4,315	+122%	+$16.6K	﹤0.01%	5435
2018 Q1	$15K	Buy	3,526 +2,231	+172%	+$7.73K	﹤0.01%	5573
2017 Q4	$4K	Sell	1,295 -9,488	-88%	-$34.6K	﹤0.01%	6155
2017 Q3	$42K	Buy	10,783 +2,308	+27%	+$8.75K	﹤0.01%	5525
2017 Q2	$37K	Buy	8,475 +475	+6%	+$1.95K	﹤0.01%	5263
2017 Q1	$29K	Hold	8,000	–	–	﹤0.01%	5438
2016 Q4	$22K	Hold	8,000	–	–	﹤0.01%	5730
2016 Q3	$26K	Buy	8,000 +2,000	+33%	+$6.54K	﹤0.01%	5444
2016 Q2	$20K	Hold	6,000	–	–	﹤0.01%	5511
2016 Q1	$14K	Hold	6,000	–	–	﹤0.01%	5631
2015 Q4	$19K	Buy	6,000 +5,000	+500%	+$16.8K	﹤0.01%	5740
2015 Q3	$3K	Hold	1,000	–	–	﹤0.01%	6323
2015 Q2	$1K	Sell	1,000 -60	-6%	-$84	﹤0.01%	6490
2015 Q1	$1K	Buy	1,060 +60	+6%	+$28	﹤0.01%	6013
2014 Q4	$0	Sell	1,000 -2,825	-74%	-$6.03K	﹤0.01%	6341
2014 Q3	$16K	Sell	3,825 -4,021	-51%	-$19.7K	﹤0.01%	5349
2014 Q2	$39K	Buy	7,846 +21	+0.3%	+$108	﹤0.01%	4969
2014 Q1	$43K	Hold	7,825	–	–	﹤0.01%	4921
2013 Q4	$47K	Sell	7,825 -100	-1%	-$682	﹤0.01%	4919
2013 Q3	$53K	Hold	7,925	–	–	﹤0.01%	4788
2013 Q2	$41K	Buy	+7,925	New	+$40.2K	﹤0.01%	4765

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Royal Bank of Canada's NYMX Position: Q3 2023 in Review

Royal Bank of Canada sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 1,430 shares.

Royal Bank of Canada first reported a position in NYMX in Q2 2013 and held it in 39 quarters. The position peaked at $53K in Q3 2013. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

Royal Bank of Canada reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 1,430 Nymox Pharmaceutical Corp shares in Q3 2023.
Royal Bank of Canada first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 39 quarters.
Royal Bank of Canada's Nymox Pharmaceutical Corp position peaked at $53K in Q3 2013.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.